申请人:Imberty Anne
公开号:US20130252910A1
公开(公告)日:2013-09-26
The present invention relates to a calixarene-based glycosylated compound (I) having the formula: (I) wherein D is independently selected in the group comprising a —CH
2
-group, an oxygen atom, a sulphur atom, a sulfinyl group or a sulfonyl group, E is independently selected in the group comprising a hydrogen, an alkyl having from 1 to 10 carbon atoms, an aryl having from 6 to 20 carbon atoms, a nitrogen dioxide group, an azide group, an amino group, a guanidinium group, a halogen atom, a —CH
2
R group wherein R is a hydroxyl, a halogen, an amino group, a N(alkyl)
2
group, a NH(alkyl) group, or E represents a —CO—R′ wherein R′ is a hydrogen atom, a hydroxyl group or an amino, B represents a A-C group wherein A is independently selected in the group comprising an oxygen atom, a sulfur atom, a NH group or a (CH
2
)
i
group, i being an integer from 1 to 10, C is independently selected in the group comprising a hydrogen, an alkyl, an alkenyl, an alkynyl, or C is a group of formula (II). The present invention also relates to a pharmaceutical composition characterized in that it comprises the said calixarene-based glycosylated compound (I), in combination with pharmaceutically acceptable carriers or diluents. The present invention also relates to the use of the said calixarene-based glycosylated compound (I) or the said pharmaceutical composition, for the manufacture of a drug intended to prevent or treat bacterial infections from pathogens that use lectins in the first steps of infection.
本发明涉及一种基于杯
芳烃的糖基化化合物(I),其
化学式如下:(I)其中D在以下组中独立选择:—
CH2基团、氧原子、
硫原子、亚砜基或磺酰基;E在以下组中独立选择:氢、具有1至10个碳原子的烷基、具有6至20个碳原子的芳基、亚硝基团、
叠氮基团、
氨基、
胍胺基、卤原子、— R基团(其中R是羟基、卤原子、
氨基、N(烷基)2基团、NH(烷基)基团)或E代表—CO—R'(其中R'是氢原子、羟基或
氨基),B代表A-C基团(其中A在以下组中独立选择:氧原子、
硫原子、NH基团或( )i基团,i为1至10的整数),C在以下组中独立选择:氢、烷基、烯基、炔基,或C是
化学式(II)的基团。本发明还涉及一种药物组合物,其特征在于它包括所述的基于杯
芳烃的糖基化化合物(I),与药学上可接受的载体或稀释剂结合。本发明还涉及所述的基于杯
芳烃的糖基化化合物(I)或所述的药物组合物的用途,用于制造用于预防或治疗利用凝集素进行感染起始阶段的病原体引起的细菌感染的药物。